PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer

BACKGROUND: Proteasome 26S subunit ATPase 2 (PSMC2) is a part of the 19S regulatory complex, which catalyzes the unfolding and transport of substrates into the 20S proteasome. Our previous research demonstrated that PSMC2 participates in the tumorigenesis and progression of pancreatic cancer (PC). H...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wei, Qian, Zhengtao, Shi, Yuxin, Zhang, Zheming, Hou, Rui, Mei, Jie, Xu, Junying, Ding, Junli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423611/
https://www.ncbi.nlm.nih.gov/pubmed/37581119
http://dx.doi.org/10.2147/PGPM.S418533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423611/
https://www.ncbi.nlm.nih.gov/pubmed/37581119
http://dx.doi.org/10.2147/PGPM.S418533

Ejemplares similares